Skip to content

Clinical trials

Phase 3 Prostatic Neoplasms trials in Ireland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 3 Country / region: Ireland Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20031
20051
20083
20091
20101
20124
20131
20142
20152
20171
20193
20201
20221
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Active, not recruiting8
Recruiting3
Terminated3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC5
University of Sydney3
Abbott2
AstraZeneca2
Bristol-Myers Squibb2
European Organisation for Research and Treatment of Cancer - EORTC2
Exelixis2
Bayer1
Celgene1
Cougar Biotechnology, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms30
Neoplasms2
Pain2
Breast Neoplasms1
Bulbo-Spinal Atrophy, X-Linked1
Colorectal Neoplasms1
Neoplasm Metastasis1
Recurrence1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.